Header Logo

Connection

Ryan Holstead to Programmed Cell Death 1 Receptor

This is a "connection" page, showing publications Ryan Holstead has written about Programmed Cell Death 1 Receptor.
  1. Kartolo A, Deluce J, Holstead R, Hopman W, Lenehan J, Baetz T. Impact of Baseline Corticosteroids on Immunotherapy Efficacy in Patients With Advanced Melanoma. J Immunother. 2021 05 01; 44(4):167-174.
    View in: PubMed
    Score: 0.044
  2. Kartolo A, Holstead R, Hopman W, Baetz T. Prognosticating role of serum eosinophils on immunotherapy efficacy in patients with advanced melanoma. Immunotherapy. 2021 02; 13(3):217-225.
    View in: PubMed
    Score: 0.043
  3. Kartolo A, Holstead R, Khalid S, Emack J, Hopman W, Robinson A, Baetz T. Serum neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in prognosticating immunotherapy efficacy. Immunotherapy. 2020 08; 12(11):785-798.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.